These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7002419)

  • 1. Drug kinetics in burn patients.
    Sawchuk RJ; Rector TS
    Clin Pharmacokinet; 1980; 5(6):548-56. PubMed ID: 7002419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of systemically administered antibiotics in patients with thermal injury.
    Boucher BA; Kuhl DA; Hickerson WL
    Clin Infect Dis; 1992 Feb; 14(2):458-63. PubMed ID: 1554831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiology and pharmacokinetics following burn injury.
    Bonate PL
    Clin Pharmacokinet; 1990 Feb; 18(2):118-30. PubMed ID: 2180612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An experimental evaluation of the germicidal efficacy of three topical antimicrobial agents in burns.
    Rode H; de Wet PM; Davies MR; Cywes S
    Prog Pediatr Surg; 1981; 14():189-208. PubMed ID: 7221007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Acute renal insufficiency caused by burn injury].
    Zogović J; Mladenović Lj
    Srp Arh Celok Lek; 1996; 124(9-10):241-5. PubMed ID: 9102856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacokinetics in patients with burns.
    Jaehde U; Sörgel F
    Clin Pharmacokinet; 1995 Jul; 29(1):15-28. PubMed ID: 7586895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic absorption of amphotericin B with topical 5% mafenide acetate/amphotericin B solution for grafted burn wounds: is it clinically relevant?
    Pendleton RA; Holmes JH
    Burns; 2010 Feb; 36(1):38-41. PubMed ID: 19481350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinectics of vancomycin and amikacin in the subeschar tissue fluid in patients with severe burn.
    Yang RH; Rong XZ; Hua R; Zhang T
    Burns; 2009 Feb; 35(1):75-9. PubMed ID: 18789586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug administration in patients with renal insufficiency. Minimising renal and extrarenal toxicity.
    Matzke GR; Frye RF
    Drug Saf; 1997 Mar; 16(3):205-31. PubMed ID: 9098657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of morphine and its glucuronidated metabolites in burn injuries.
    Perreault S; Choinière M; du Souich PB; Bellavance F; Beauregard G
    Ann Pharmacother; 2001 Dec; 35(12):1588-92. PubMed ID: 11793627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vancomycin elimination in patients with burn injury.
    Brater DC; Bawdon RE; Anderson SA; Purdue GF; Hunt JL
    Clin Pharmacol Ther; 1986 Jun; 39(6):631-4. PubMed ID: 3709027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of silver sulfadiazine and gentamicin for topical prophylaxis against burn wound sepsis.
    Snelling CF; Ronald AR; Waters WR; Yaworski DS; Drulak K; Sunderland M
    Can Med Assoc J; 1978 Sep; 119(5):466-70. PubMed ID: 99223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of antibiotics in burn patients.
    Weinbren MJ
    J Antimicrob Chemother; 1999 Sep; 44(3):319-27. PubMed ID: 10511398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TIMP-1, MMP-2, MMP-9, and PIIINP as serum markers for skin fibrosis in patients following severe burn trauma.
    Ulrich D; Noah EM; von Heimburg D; Pallua N
    Plast Reconstr Surg; 2003 Apr; 111(4):1423-31. PubMed ID: 12618601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacokinetics of azlocillin in the burn patient].
    Drugeon HB; Pannier M; Courtieu AL
    Presse Med; 1984 Mar; 13(13):805-7. PubMed ID: 6231599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibody to intercellular adhesion molecule-1 reduces cardiac contractile dysfunction after burn injury in rabbits.
    Horton JW; Mileski WJ; White DJ; Lipsky P
    J Surg Res; 1996 Jul; 64(1):49-56. PubMed ID: 8806473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased glomerular filtration rate in patients with major burns and its effect on the pharmacokinetics of tobramycin.
    Loirat P; Rohan J; Baillet A; Beaufils F; David R; Chapman A
    N Engl J Med; 1978 Oct; 299(17):915-9. PubMed ID: 692596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of topical epinephrine on haemodynamics and markers of tissue perfusion in burned and non-burned patients requiring skin grafting.
    Papp AA; Uusaro AV; Ruokonen ET
    Burns; 2009 Sep; 35(6):832-9. PubMed ID: 19481869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2-Mercaptoethane sulfonate (MESNA) protects against burn-induced renal injury in rats.
    Sener G; Sehirli O; Erkanli G; Cetinel S; Gedik N; Yeğen B
    Burns; 2004 Sep; 30(6):557-64. PubMed ID: 15302421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silver absorption on burns after the application of Acticoat: data from pediatric patients and a porcine burn model.
    Wang XQ; Kempf M; Mott J; Chang HE; Francis R; Liu PY; Cuttle L; Olszowy H; Kravchuk O; Mill J; Kimble RM
    J Burn Care Res; 2009; 30(2):341-8. PubMed ID: 19165102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.